wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34956830-DDCB8CFA-1BC5-459A-B6BE-620A6743F9C6
Q34956830-DDCB8CFA-1BC5-459A-B6BE-620A6743F9C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34956830-DDCB8CFA-1BC5-459A-B6BE-620A6743F9C6
A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours.
P2860
Q34956830-DDCB8CFA-1BC5-459A-B6BE-620A6743F9C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34956830-DDCB8CFA-1BC5-459A-B6BE-620A6743F9C6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
201907b781fe3c0e82762a7c4e59af865051a258
P2860
Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors.